| 持有 沃森生物(300142)的基金 |
| 报告期：2023-09-30 |
| 序号 |
基金代码 |
基金简称 |
持仓市值(元) |
持仓数量(股) |
占基金净值比例(%) |
| 1 | 161726 | 招商国证生物医药指数分级 | 746,097,616.44 | 31,694,886.00 | 5.68 |
| 2 | 512010 | 易方达沪深300医药ETF | 597,729,374.88 | 25,392,072.00 | 2.91 |
| 3 | 159992 | 银华中证创新药产业ETF | 314,615,160.20 | 13,365,130.00 | 3.68 |
| 4 | 512290 | 国泰中证生物医药ETF | 224,697,374.22 | 9,545,343.00 | 4.22 |
| 5 | 515120 | 广发中证创新药产业ETF | 140,806,087.18 | 5,981,567.00 | 3.73 |
| 6 | 501010 | 汇添富中证生物科技指数(LOF)C | 115,349,366.22 | 4,900,143.00 | 3.71 |
| 7 | 501009 | 汇添富中证生物科技指数(LOF)A | 115,349,366.22 | 4,900,143.00 | 3.71 |
| 8 | 159938 | 广发中证全指医药卫生ETF | 92,634,914.02 | 3,935,213.00 | 1.67 |
| 9 | 159929 | 汇添富中证医药卫生ETF | 39,028,260.70 | 1,657,955.00 | 1.89 |
| 10 | 161122 | 易方达生物科技指数分级 | 37,432,507.64 | 1,590,166.00 | 4.05 |
| 11 | 515950 | 富国中证医药50ETF | 32,101,498.00 | 1,363,700.00 | 2.82 |
| 12 | 005121 | 富国兴利增强债券 | 19,467,580.00 | 827,000.00 | 0.46 |
| 13 | 160219 | 国泰国证医药卫生行业指数分级 | 17,308,914.92 | 735,298.00 | 1.85 |
| 14 | 512120 | 华安中证细分医药ETF | 9,287,942.40 | 394,560.00 | 2.63 |
| 15 | 165519 | 信诚中证800医药指数分级 | 6,610,032.00 | 280,800.00 | 2.53 |
| 16 | 163118 | 申万菱信中证申万医药生物指数分级 | 4,521,916.30 | 192,095.00 | 1.64 |
| 17 | 008551 | 东财医药指数发起A | 2,335,168.00 | 99,200.00 | 1.80 |
| 18 | 008552 | 东财医药指数发起C | 2,335,168.00 | 99,200.00 | 1.80 |
| 19 | 005947 | 德邦民裕进取量化精选灵活配置混合A | 2,304,707.24 | 97,906.00 | 4.37 |
| 20 | 005948 | 德邦民裕进取量化精选灵活配置混合C | 2,304,707.24 | 97,906.00 | 4.37 |
| 21 | 010366 | 鹏华中证医药指数(LOF)C | 2,278,672.00 | 96,800.00 | 1.78 |
| 22 | 160635 | 鹏华中证医药指数(LOF)A | 2,278,672.00 | 96,800.00 | 1.78 |
| 23 | 001180 | 广发医药卫生联接A | 91,806.00 | 3,900.00 | 0.00 |
| 24 | 002978 | 广发医药卫生联接C | 91,806.00 | 3,900.00 | 0.00 |
| 25 | 007077 | 添富中证医药ETF联接C | 28,248.00 | 1,200.00 | 0.01 |
| 26 | 007076 | 添富中证医药ETF联接A | 28,248.00 | 1,200.00 | 0.01 |
